MAXX Performance Inc. New Ingredients / New Technologies / New Solutions
Technology Partners
Home Our Process Markets Our Company
Our Company - Management
Winston A. Samuels, Ph.D.
Winston A. Samuels, Ph.D.
President and Chief Executive Officer
Maxx Performance Inc.
P.O. Box 711
Chester, NY 10918
(845) 987-9432 -- Tel
winston.samuels@maxxperform.com

Winston A. Samuels, Ph.D., is the president and chief executive officer of Maxx Performance Inc. He has 22 years of experience in food and nutrition, animal nutrition and health, and pharmaceutical and biochemical industries.

Samuels was formerly executive officer of Balchem Corporation, and vice president and general manager of Balchem Encapsulates, a division of Balchem Corporation in New Hampton, N.Y., which specializes in the development of microencapsulated solutions for multiple food, nutrition, animal and pharmaceutical markets.

Under Samuels' leadership and contribution, Balchem was recognized by BusinessWeek and Forbes as one of the 100 Hottest Growth Companies in 2002. He created an applications solution focused culture within Balchem Encapsulates and drove sales growth 6, 33, 40 and 53%. The revenue growth generated by Samuels' strategic management style for the encapsulates business segment boosted the company's stock price from $4 a share when he joined Balchem, to $23 a share when he left the company.

Prior to joining Balchem Encapsulates, Samuels was director of growth and commercial development for Solutia, Inc., a spin-off of the Monsanto Company, and a leading manufacturer of food phosphates. At Solutia, Samuels drove the process that led to the acquisition of a pharmaceutical intermediate business and championed the expansion of its products into new applications and new markets.

Samuels first joined Monsanto in 1985 as senior research biologist and quickly progressed through the ranks. Samuels managed Monsanto's $200 million technical phosphate business and played a key role in the global commercial development and successful launch, commercialization and sales of Posilac Bovine Somatotropin, the first large-scale biotechnology drug to improve production efficiencies in lactating dairy cows.

Samuels holds a doctorate and master's degree in nutrition and animal science from Virginia Polytechnic Institute and State University (Virginia Tech). His undergraduate degree is in animal and poultry sciences from Tuskegee University. He successfully completed business and management training at the University of Virginia Darden School of Business and Washington University School of Business.

He is a member of the Institute of Food Technologists, American Dairy Science Association, American Society of Animal Science and The Conference Board. Samuels is also an avid ice hockey fan and manager of a high school varsity and junior varsity ice hockey program.

Back to Management

Contact Us Tel: 845.987.9432